These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33404144)

  • 1. Symmetrical glial hyperplasia in the brainstem of fibrodysplasia ossificans progressiva.
    Mori S; Suzuki SO; Honda H; Hamasaki H; Sakae N; Sasagasako N; Furuya H; Iwaki T
    Neuropathology; 2021 Apr; 41(2):146-151. PubMed ID: 33404144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1
    Convente MR; Chakkalakal SA; Yang E; Caron RJ; Zhang D; Kambayashi T; Kaplan FS; Shore EM
    J Bone Miner Res; 2018 Feb; 33(2):269-282. PubMed ID: 28986986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Chinese girl with fibrodysplasia ossificans progressiva caused by a de novo mutation R206H in ACVR1 gene].
    Zhou Q; Meng Y; Su L; Zhao SM; Shi HP; Huang SZ
    Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):215-9. PubMed ID: 19099712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1.
    Kaplan FS; Xu M; Seemann P; Connor JM; Glaser DL; Carroll L; Delai P; Fastnacht-Urban E; Forman SJ; Gillessen-Kaesbach G; Hoover-Fong J; Köster B; Pauli RM; Reardon W; Zaidi SA; Zasloff M; Morhart R; Mundlos S; Groppe J; Shore EM
    Hum Mutat; 2009 Mar; 30(3):379-90. PubMed ID: 19085907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrodysplasia ossificans progressiva: clinical and genetic aspects.
    Pignolo RJ; Shore EM; Kaplan FS
    Orphanet J Rare Dis; 2011 Dec; 6():80. PubMed ID: 22133093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midline brain hamartomatous lesions in fibrodysplasia ossificans progressiva with ACVR1 mutations.
    Kresak JL; Walsh M; Tuzzolo A; Ordulu Z; Gregory J
    Neuropathology; 2023 Aug; 43(4):333-339. PubMed ID: 36642816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H).
    Furuya H; Ikezoe K; Wang L; Ohyagi Y; Motomura K; Fujii N; Kira J; Fukumaki Y
    Am J Med Genet A; 2008 Feb; 146A(4):459-63. PubMed ID: 18203193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of Fibrodysplasia Ossificans Progressiva associated with a novel variant of the ACVR1 gene.
    Cappato S; Traberg R; Gintautiene J; Zara F; Bocciardi R
    Mol Genet Genomic Med; 2021 Oct; 9(10):e1774. PubMed ID: 34347384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classical and atypical Fibrodysplasia Ossificans Progressiva in India.
    Madhuri V; Santhanam M; Sugumar LK; Rajagopal K; Chilbule SK
    Ann Hum Genet; 2015 Jul; 79(4):245-52. PubMed ID: 26058333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with ACVR1
    Kou S; De Cunto C; Baujat G; Wentworth KL; Grogan DR; Brown MA; Di Rocco M; Keen R; Al Mukaddam M; le Quan Sang KH; Masharani U; Kaplan FS; Pignolo RJ; Hsiao EC
    Orphanet J Rare Dis; 2020 Jul; 15(1):193. PubMed ID: 32727600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ACVR1 617G>A mutation is also recurrent in three Japanese patients with fibrodysplasia ossificans progressiva.
    Nakajima M; Haga N; Takikawa K; Manabe N; Nishimura G; Ikegawa S
    J Hum Genet; 2007; 52(5):473-475. PubMed ID: 17351709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morpholino-Mediated Exon Skipping Targeting Human ACVR1/ALK2 for Fibrodysplasia Ossificans Progressiva.
    Maruyama R; Yokota T
    Methods Mol Biol; 2018; 1828():497-502. PubMed ID: 30171563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal malformations and developmental arthropathy in individuals who have fibrodysplasia ossificans progressiva.
    Towler OW; Shore EM; Kaplan FS
    Bone; 2020 Jan; 130():115116. PubMed ID: 31655222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACVR1 (587T>C) mutation in a variant form of fibrodysplasia ossificans progressiva: second report.
    Nakahara Y; Katagiri T; Ogata N; Haga N
    Am J Med Genet A; 2014 Jan; 164A(1):220-4. PubMed ID: 24259422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ACVR1
    Kaplan FS; Groppe JC; Xu M; Towler OW; Grunvald E; Kalunian K; Kallish S; Al Mukaddam M; Pignolo RJ; Shore EM
    Am J Med Genet A; 2022 Mar; 188(3):806-817. PubMed ID: 34854557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACVR1 p.Q207E causes classic fibrodysplasia ossificans progressiva and is functionally distinct from the engineered constitutively active ACVR1 p.Q207D variant.
    Haupt J; Deichsel A; Stange K; Ast C; Bocciardi R; Ravazzolo R; Di Rocco M; Ferrari P; Landi A; Kaplan FS; Shore EM; Reissner C; Seemann P
    Hum Mol Genet; 2014 Oct; 23(20):5364-77. PubMed ID: 24852373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phenotype and genotype of fibrodysplasia ossificans progressiva in China: a report of 72 cases.
    Zhang W; Zhang K; Song L; Pang J; Ma H; Shore EM; Kaplan FS; Wang P
    Bone; 2013 Dec; 57(2):386-91. PubMed ID: 24051199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A.
    Hatsell SJ; Idone V; Wolken DM; Huang L; Kim HJ; Wang L; Wen X; Nannuru KC; Jimenez J; Xie L; Das N; Makhoul G; Chernomorsky R; D'Ambrosio D; Corpina RA; Schoenherr CJ; Feeley K; Yu PB; Yancopoulos GD; Murphy AJ; Economides AN
    Sci Transl Med; 2015 Sep; 7(303):303ra137. PubMed ID: 26333933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allele-Selective LNA Gapmers for the Treatment of Fibrodysplasia Ossificans Progressiva Knock Down the Pathogenic ACVR1
    Maruyama R; Nguyen Q; Roshmi RR; Touznik A; Yokota T
    Nucleic Acid Ther; 2022 Jun; 32(3):185-193. PubMed ID: 35085461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-system involvement in a severe variant of fibrodysplasia ossificans progressiva (ACVR1 c.772G>A; R258G): A report of two patients.
    Kaplan FS; Kobori JA; Orellana C; Calvo I; Rosello M; Martinez F; Lopez B; Xu M; Pignolo RJ; Shore EM; Groppe JC
    Am J Med Genet A; 2015 Oct; 167A(10):2265-71. PubMed ID: 26097044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.